Product Name: Human RSV-F Antibody (Motavizumab, Research Use)
Catalog Number: NBR-0961
Target Name: RSV-F
Trade Name: Motavizumab
Antibody Drug Description: Motavizumab is a second generation monoclonal antibody (mAb) derived from palivizumab (Synagis) using affinity maturation techniques. Motavizumab is currently undergoing US Food and Drug Administration review as a treatment for respiratory syncytial virus (RSV) prophylaxis. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: RSV-F
Synonyms: 
Target Description: 
Ensembl: 
Uniprot: